Purchase Order 75F40124P00531
Award Date
9/29/24
Potential Completion Date
11/14/27
Potential Value
$85K
Federal Agency
Food and Drug Administration
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson And Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Laurel, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD), a global medical technology manufacturer, for the preventative and corrective maintenance of a FACSCANTO II flow cytometer, computer workstation, and three lasers. The $85,991.40 contract has an ultimate completion date of September 25, 2025 and was awarded on July 28, 2021. The award is not associated with a set-aside program. BD has a long history of providing...
The U.S. Food and Drug Administration (FDA) awarded a $431,505.49 firm-fixed-price delivery order contract to Becton, Dickinson and Company (BD) for a flow cytometry system with 5 one-year post-warranty maintenance options. The contract is not set aside. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications. The delivery order likely supports the FDA's work in evaluating and approving medical...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for preventative and corrective maintenance services on a BD FACSCanto II flow cytometer and BD High Throughput Sampler. The contract has a base period plus four one-year option periods, with a total potential value of $99,837.60. The contract was not set aside for small businesses. BD, a large medical technology manufacturer, has an extensive portfolio of...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Becton, Dickinson and Company (BD) for $191,698.20 to provide post-warranty preventive maintenance and repair service on a BD LSRFortessa X-20 SORP flow cytometer system. The award has an ultimate completion date of November 26, 2028 and does not utilize a small business set-aside. BD is a global medical technology company that has an extensive portfolio of federal...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) for a maintenance agreement on a FACS Celesta flow cytometer with a high throughput sampler. The potential value of the contract is $24,444.00, with a completion date of August 23, 2020. BD is a global medical technology company that provides instruments, reagents, and services for...
This federal contract award is for preventative maintenance and repair services for FACSCANTO II flow cytometers. The contract was awarded to Becton, Dickinson and Company (BD), a major supplier of flow cytometry equipment, cell imaging technologies, and genomics solutions to federal agencies. The contract has a ceiling value of $87,586.20 and a term through September 13, 2028. This is a delivery order contract with a firm fixed-price pricing structure, awarded by the Food and Drug...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for preventative and corrective/remedial maintenance and repair services for a FACSCANTO II flow cytometer and high throughput sampler. The $81,488.60 fixed-price contract has an ultimate completion date of September 13, 2023 and was awarded on August 23, 2018 under the Scientific Equipment and Services (FSS-66) multiple award schedule contract. The contract does not have a...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for the procurement of a FACSCELESTA flow cytometer system. The contract has a total ceiling value of $138,245.75 and a period of performance ending on August 22, 2017. BD is a global medical technology company that provides a wide range of goods and services, including flow cytometers, reagents, and associated maintenance, to various U.S. government...
This is a federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, to provide preventative maintenance for a FACSCANTO II instrument. The contract, valued at $41,844.00, was awarded by the Food and Drug Administration (FDA), a civilian agency, and does not have a set-aside designation. BD is a major supplier of medical instruments, reagents, and services to various U.S. government agencies, including the Department of Veterans Affairs, National...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for a preventive maintenance agreement on a BD LSRFortessa X-20 flow cytometer. The contract has a ceiling value of $186,838.20 and a period of performance through July 3, 2028. The contract was not set aside for small businesses. BD is a large, established medical technology manufacturer that has a long history of providing specialized flow cytometry...